Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

The Securities and Exchange Board of India (SEBI) has collaborated with DigiLocker, a digital document wallet, to address the ...

Understanding your tumor biology is key to finding the right treatment for pancreatic cancer. Identifying mutations, or changes in a [...] READ MORE ...

Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...

In 2024, we made tremendous progress across our pipeline programs, most notably the NDA acceptance of our novel-novel combination of ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

Potentially best-in-class RAS-targeting franchise advancing with both ERAS-0015 and ERAS-4001 expected to enter the clinic in 2025 Ongoing Phase 3 SEACRAFT-2 registrational trial progressing well with ...

Maxim lowered the firm’s price target on Silexion Therapeutics (SLXN) to $5 from $9 and keeps a Buy rating on the shares after its Q4 results. The ...

SEBI has collaborated with DigiLocker to allow investors to securely store and access demat and mutual fund statements, ...

SEBI Partners with DigiLocker to Reduce Unclaimed Assets, Boost Investor Protection - The Securities and Exchange Board of India (SEBI) has joined hands with DigiLocker , a ...

After the user's death, DigiLocker automatically notifies the nominated individuals (DigiLocker Nominees) via SMS and email, ...

Market regulator Securities and Exchange Board of India (SEBI) has announced a major initiative aimed at reducing unclaimed ...